Biotech Values

[genisi]

One point I would like to know (if the KOL-type HCV docs mentioned it in the panel, please post), is whether IL-28b status would be also correlated with SVR in interferon-free combos, or is it just an interferon-containing regimen related association. I think not, i.e. the CC genotype should have higher response in any case since it likely has better viral clearance (due to the endogenous interferon system).